Breaking News Instant updates and real-time market news.

NMTR

9 Meters Biopharma

/

+

08:27
01/24/22
01/24
08:27
01/24/22
08:27

9 Meters Biopharma patent for NM-102 approved

The patent demonstrates that NM-102, which can prevent disruption of and/or restore the functional integrity of the ileal and/or colonic intestinal barrier, can improve the benefit of immune checkpoint inhibitors for cancer treatment. Specifically, it demonstrates that NM-102 has utility as an anticancer therapy, specifically in combination with the two major pillars of cancer immunotherapy: anti-PD1 and anti-CTLA4 antibody treatments. Previous proof-of-concept animal studies have shown NM-102 to both slow tumor progression and enhance the efficacy of ICIs.

  • 31

    Mar

OTHER BREAKING NEWS FROM THE FLY

Hot Stocks
Celularity announces $30M private placement » 08:36
05/18/22
05/18
08:36
05/18/22
08:36
CELU

Celularity

$7.60 /

+1.14 (+17.65%)

Celularity announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CELU Celularity
$7.60 /

+1.14 (+17.65%)

CELU Celularity
$7.60 /

+1.14 (+17.65%)

04/06/22 Truist
Celularity downgraded to Hold from Buy at Truist
04/01/22 Oppenheimer
Celularity price target raised to $10 from $9 at Oppenheimer
01/27/22 Oppenheimer
Celularity initiated with an Outperform at Oppenheimer
11/24/21 Morgan Stanley
Celularity initiated with an Equal Weight at Morgan Stanley
CELU Celularity
$7.60 /

+1.14 (+17.65%)

CELU Celularity
$7.60 /

+1.14 (+17.65%)

Recommendations
Adobe price target lowered to $525 from $600 at Wells Fargo » 08:36
05/18/22
05/18
08:36
05/18/22
08:36
ADBE

Adobe

$409.54 /

+6.48 (+1.61%)

Wells Fargo analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ADBE Adobe
$409.54 /

+6.48 (+1.61%)

ADBE Adobe
$409.54 /

+6.48 (+1.61%)

03/29/22 Exane BNP Paribas
Adobe initiated with an Outperform at Exane BNP Paribas
03/28/22 Argus
Adobe price target lowered to $575 from $764 at Argus
03/23/22 Jefferies
Adobe Creative Cloud price increases smaller than expected, says Jefferies
03/23/22 Deutsche Bank
Adobe price target lowered to $575 from $660 at Deutsche Bank
ADBE Adobe
$409.54 /

+6.48 (+1.61%)

ADBE Adobe
$409.54 /

+6.48 (+1.61%)

ADBE Adobe
$409.54 /

+6.48 (+1.61%)

ADBE Adobe
$409.54 /

+6.48 (+1.61%)

Hot Stocks
Target expects to reach high end of $4B-$5B CapEx plan for the year  08:35
05/18/22
05/18
08:35
05/18/22
08:35
TGT

Target

$215.30 /

-2.95 (-1.35%)

 
ShowHide Related Items >><<
TGT Target
$215.30 /

-2.95 (-1.35%)

TGT Target
$215.30 /

-2.95 (-1.35%)

08:30 Today Truist
Target downgraded to Hold from Buy at Truist
05/16/22 Deutsche Bank
Target price target lowered to $294 from $353 at Deutsche Bank
05/16/22 Stifel
Target price target lowered to $270 from $280 at Stifel
04/08/22 Gordon Haskett
Gordon Haskett upgrades Target on 'remarkably consistent' traffic trends
TGT Target
$215.30 /

-2.95 (-1.35%)

TGT Target
$215.30 /

-2.95 (-1.35%)

TGT Target
$215.30 /

-2.95 (-1.35%)

TGT Target
$215.30 /

-2.95 (-1.35%)

Recommendations
VF Corp. price target lowered to $71 from $90 at BTIG » 08:35
05/18/22
05/18
08:35
05/18/22
08:35
VFC

VF Corp.

$48.21 /

+1.3 (+2.77%)

BTIG analyst Camilo Lyon…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VFC VF Corp.
$48.21 /

+1.3 (+2.77%)

VFC VF Corp.
$48.21 /

+1.3 (+2.77%)

07:34 Today Cowen
VF Corp. price target lowered to $61 from $72 at Cowen
05/16/22 Deutsche Bank
VF Corp. price target lowered to $64 from $86 at Deutsche Bank
05/13/22 UBS
VF Corp. price target lowered to $55 from $65 at UBS
04/06/22 Piper Sandler
Piper lists winners and losers from semi-annual teen survey
VFC VF Corp.
$48.21 /

+1.3 (+2.77%)

VFC VF Corp.
$48.21 /

+1.3 (+2.77%)

VFC VF Corp.
$48.21 /

+1.3 (+2.77%)

Hot Stocks
Veru appoints Batten as EVP, Head of US Infectious Disease Franchise » 08:34
05/18/22
05/18
08:34
05/18/22
08:34
VERU

Veru

$15.60 /

+2.085 (+15.43%)

Veru announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VERU Veru
$15.60 /

+2.085 (+15.43%)

VERU Veru
$15.60 /

+2.085 (+15.43%)

05/13/22 Jefferies
Veru price target raised to $55 from $33 at Jefferies
04/12/22 Oppenheimer
Veru price target raised to $36 from $25 at Oppenheimer
04/11/22 Cantor Fitzgerald
Veru's Covid data highlights multiple shots on goal, says Cantor Fitzgerald
VERU Veru
$15.60 /

+2.085 (+15.43%)

VERU Veru
$15.60 /

+2.085 (+15.43%)

VERU Veru
$15.60 /

+2.085 (+15.43%)

VERU Veru
$15.60 /

+2.085 (+15.43%)

Hot Stocks
AgeX Therapeutics appoints Joanne Hackett as chairperson » 08:34
05/18/22
05/18
08:34
05/18/22
08:34
AGE

AgeX Therapeutics

/

+

AgeX Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AGE AgeX Therapeutics
/

+

Hot Stocks
Genius Brands signs 20-year deal with Marvel Studies to license 'Stan Lee' » 08:34
05/18/22
05/18
08:34
05/18/22
08:34
GNUS

Genius Brands

/

+

, DIS

Disney

$108.66 /

+3.475 (+3.30%)

"Stan Lee…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GNUS Genius Brands
/

+

DIS Disney
$108.66 /

+3.475 (+3.30%)

GNUS Genius Brands
/

+

12/15/21 Dawson James
Genius Brands initiated with a Buy at Dawson James
DIS Disney
$108.66 /

+3.475 (+3.30%)

05/16/22 Stifel
Trade Desk upgraded to Buy from Hold at Stifel
05/13/22 Barclays
Disney price target lowered to $130 from $168 at Barclays
05/12/22 RBC Capital
Disney price target lowered to $176 from $210 at RBC Capital
05/12/22 BMO Capital
Disney price target lowered to $135 from $140 at BMO Capital
GNUS Genius Brands
/

+

DIS Disney
$108.66 /

+3.475 (+3.30%)

DIS Disney
$108.66 /

+3.475 (+3.30%)

GNUS Genius Brands
/

+

DIS Disney
$108.66 /

+3.475 (+3.30%)

GNUS Genius Brands
/

+

DIS Disney
$108.66 /

+3.475 (+3.30%)

Hot Stocks
TC Biopharm forms scientific advisroy board for cell therapy development » 08:34
05/18/22
05/18
08:34
05/18/22
08:34
TCBP

TC Biopharm

/

+

TC Biopharm announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TCBP TC Biopharm
/

+

TCBP TC Biopharm
/

+

  • 11
    Feb
TCBP TC Biopharm
/

+

Recommendations
Valero price target raised to $136 from $126 at Wells Fargo » 08:33
05/18/22
05/18
08:33
05/18/22
08:33
VLO

Valero

$128.06 /

+0.24 (+0.19%)

Wells Fargo analyst Roger…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VLO Valero
$128.06 /

+0.24 (+0.19%)

VLO Valero
$128.06 /

+0.24 (+0.19%)

05/17/22 JPMorgan
Valero price target raised to $142 from $111 at JPMorgan
04/27/22 Cowen
Valero price target raised to $116 from $106 at Cowen
04/27/22 RBC Capital
Valero price target raised to $120 from $108 at RBC Capital
04/27/22 Barclays
Valero price target raised to $120 from $114 at Barclays
VLO Valero
$128.06 /

+0.24 (+0.19%)

VLO Valero
$128.06 /

+0.24 (+0.19%)

VLO Valero
$128.06 /

+0.24 (+0.19%)

Technical Analysis
Nasdaq Composite: Pivot points » 08:33
05/18/22
05/18
08:33
05/18/22
08:33
$COMP

Nasdaq Composite

/

+

The following are the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$COMP Nasdaq Composite
/

+

$COMP Nasdaq Composite
/

+

$COMP Nasdaq Composite
/

+

$COMP Nasdaq Composite
/

+

$COMP Nasdaq Composite
/

+

Hot Stocks
ChemoCentryx announces presentation on role of tunnels in HS » 08:33
05/18/22
05/18
08:33
05/18/22
08:33
CCXI

ChemoCentryx

$20.91 /

+1.695 (+8.82%)

ChemoCentryx announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CCXI ChemoCentryx
$20.91 /

+1.695 (+8.82%)

CCXI ChemoCentryx
$20.91 /

+1.695 (+8.82%)

03/02/22 Raymond James
ChemoCentryx could beat consensus 'handily' in Q2, says Raymond James
03/02/22 Stifel
ChemoCentryx's Q4 was positive-launch quarter, says Stifel
11/15/21 Raymond James
InflaRx's ANCA vasculitis data 'solid,' says Raymond James
11/10/21 Raymond James
ChemoCentryx price target raised to $110 from $107 at Raymond James
CCXI ChemoCentryx
$20.91 /

+1.695 (+8.82%)

CCXI ChemoCentryx
$20.91 /

+1.695 (+8.82%)

Recommendations
Plymouth Industrial REIT price target lowered to $24 from $30 at Truist » 08:32
05/18/22
05/18
08:32
05/18/22
08:32
PLYM

Plymouth Industrial REIT

$21.29 /

+ (+0.00%)

Truist analyst Anthony…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PLYM Plymouth Industrial REIT
$21.29 /

+ (+0.00%)

PLYM Plymouth Industrial REIT
$21.29 /

+ (+0.00%)

06:25 Today JMP Securities
Plymouth Industrial REIT downgraded to Market Perform from Outperform at JMP Securities
05/12/22 B. Riley
Plymouth Industrial REIT price target lowered to $29 from $32 at B. Riley
03/02/22 B. Riley
Plymouth Industrial REIT resumed with a Buy at B. Riley
02/07/22 BMO Capital
Plymouth Industrial REIT initiated with a Market Perform at BMO Capital
PLYM Plymouth Industrial REIT
$21.29 /

+ (+0.00%)

PLYM Plymouth Industrial REIT
$21.29 /

+ (+0.00%)

Upgrade
Roth Capital upgrades Salesforce to Buy with $242 price target » 08:31
05/18/22
05/18
08:31
05/18/22
08:31
CRM

Salesforce

$163.74 /

-0.47 (-0.29%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CRM Salesforce
$163.74 /

-0.47 (-0.29%)

CRM Salesforce
$163.74 /

-0.47 (-0.29%)

08:24 Today Roth Capital
Salesforce upgraded to Buy from Neutral at Roth Capital
06:42 Today Mizuho
Salesforce price target lowered to $225 from $295 at Mizuho
05/17/22 UBS
Salesforce price target lowered to $185 from $225 at UBS
05/16/22 Morgan Stanley
Salesforce price target lowered to $291 from $360 at Morgan Stanley
CRM Salesforce
$163.74 /

-0.47 (-0.29%)

CRM Salesforce
$163.74 /

-0.47 (-0.29%)

CRM Salesforce
$163.74 /

-0.47 (-0.29%)

CRM Salesforce
$163.74 /

-0.47 (-0.29%)

Hot Stocks
American Resources signs offtake, financial partnership with Integrity Coal » 08:31
05/18/22
05/18
08:31
05/18/22
08:31
AREC

American Resources

$1.57 /

+0.18 (+13.00%)

American Resources…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AREC American Resources
$1.57 /

+0.18 (+13.00%)

AREC American Resources
$1.57 /

+0.18 (+13.00%)

AREC American Resources
$1.57 /

+0.18 (+13.00%)

Downgrade
Target downgraded to Hold from Buy at Truist » 08:30
05/18/22
05/18
08:30
05/18/22
08:30
TGT

Target

$215.30 /

-2.95 (-1.35%)

Truist analyst Scot…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TGT Target
$215.30 /

-2.95 (-1.35%)

TGT Target
$215.30 /

-2.95 (-1.35%)

05/16/22 Deutsche Bank
Target price target lowered to $294 from $353 at Deutsche Bank
05/16/22 Stifel
Target price target lowered to $270 from $280 at Stifel
04/08/22 Gordon Haskett
Gordon Haskett upgrades Target on 'remarkably consistent' traffic trends
04/08/22 Gordon Haskett
Target upgraded to Buy from Hold at Gordon Haskett
TGT Target
$215.30 /

-2.95 (-1.35%)

TGT Target
$215.30 /

-2.95 (-1.35%)

TGT Target
$215.30 /

-2.95 (-1.35%)

TGT Target
$215.30 /

-2.95 (-1.35%)

Options
Twelve new option listings on May 18th » 08:30
05/18/22
05/18
08:30
05/18/22
08:30
CYN

Cyngn

$2.59 /

-0.195 (-7.00%)

, FNTC

FinTech

$14.55 /

+0.61 (+4.38%)

, RVAC

Riverview Acquisition

$9.88 /

+0.02 (+0.20%)

, SEA

Star Maritime Acquisition

$21.13 /

+0.6 (+2.92%)

, NETZ

Netzee Inc

$48.92 /

+1.23 (+2.58%)

New option listings for…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CYN Cyngn
$2.59 /

-0.195 (-7.00%)

RVAC Riverview Acquisition
$9.88 /

+0.02 (+0.20%)

CYN Cyngn
$2.59 /

-0.195 (-7.00%)

11/16/21 Aegis
Cyngn initiated with a Buy at Aegis
FNTC FinTech
$14.55 /

+0.61 (+4.38%)

RVAC Riverview Acquisition
$9.88 /

+0.02 (+0.20%)

SEA Star Maritime Acquisition
$21.13 /

+0.6 (+2.92%)

NETZ Netzee Inc
$48.92 /

+1.23 (+2.58%)

  • 20
    Oct
RVAC Riverview Acquisition
$9.88 /

+0.02 (+0.20%)

RVAC Riverview Acquisition
$9.88 /

+0.02 (+0.20%)

Hot Stocks
9 Meters Biopharma presents preclinical data on larazotide » 08:29
05/18/22
05/18
08:29
05/18/22
08:29
NMTR

9 Meters Biopharma

/

+

9 Meters Biopharma…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NMTR 9 Meters Biopharma
/

+

NMTR 9 Meters Biopharma
/

+

07/08/21 BMO Capital
9 Meters Biopharma initiated with an Outperform at BMO Capital
06/04/21 Citi
9 Meters Biopharma initiated with a Buy at Citi
05/26/21 Truist
9 Meters' larazotide has potential application in syndrome, says Truist
NMTR 9 Meters Biopharma
/

+

Initiation
ServiceNow initiated with an Overweight at Wells Fargo » 08:28
05/18/22
05/18
08:28
05/18/22
08:28
NOW

ServiceNow

$432.73 /

-0.07 (-0.02%)

Wells Fargo analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NOW ServiceNow
$432.73 /

-0.07 (-0.02%)

NOW ServiceNow
$432.73 /

-0.07 (-0.02%)

05/10/22 Truist
ServiceNow price target lowered to $600 from $700 at Truist
04/28/22 BMO Capital
ServiceNow price target raised to $595 from $570 at BMO Capital
04/28/22 Morgan Stanley
ServiceNow price target lowered to $745 from $810 at Morgan Stanley
04/28/22 Oppenheimer
ServiceNow price target lowered to $600 from $660 at Oppenheimer
NOW ServiceNow
$432.73 /

-0.07 (-0.02%)

NOW ServiceNow
$432.73 /

-0.07 (-0.02%)

NOW ServiceNow
$432.73 /

-0.07 (-0.02%)

Hot Stocks
Apollo Endosurgery to highlight products at DDW 2022 » 08:27
05/18/22
05/18
08:27
05/18/22
08:27
APEN

Apollo Endosurgery

$4.14 /

+0.04 (+0.98%)

Apollo Endosurgery…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
APEN Apollo Endosurgery
$4.14 /

+0.04 (+0.98%)

APEN Apollo Endosurgery
$4.14 /

+0.04 (+0.98%)

02/23/22 Piper Sandler
Apollo Endosurgery price target lowered to $12 from $14 at Piper Sandler
12/28/21 Lake Street
Lake Street names 18 small cap best ideas for 2022
12/15/21 Cowen
Apollo Endosurgery initiated with an Outperform at Cowen
12/09/21 Stifel
Apollo Endosurgery initiated with a Buy at Stifel
APEN Apollo Endosurgery
$4.14 /

+0.04 (+0.98%)

  • 13
    Oct
Recommendations
Home Depot price target lowered to $330 from $354 at DA Davidson » 08:26
05/18/22
05/18
08:26
05/18/22
08:26
HD

Home Depot

$300.89 /

+4.85 (+1.64%)

DA Davidson analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HD Home Depot
$300.89 /

+4.85 (+1.64%)

HD Home Depot
$300.89 /

+4.85 (+1.64%)

07:30 Today Guggenheim
Home Depot price target lowered to $350 from $400 at Guggenheim
07:12 Today Wedbush
Home Depot price target lowered to $320 from $340 at Wedbush
06:43 Today Raymond James
Home Depot price target lowered to $340 from $350 at Raymond James
06:34 Today Piper Sandler
Home Depot price target raised to $321 from $310 at Piper Sandler
HD Home Depot
$300.89 /

+4.85 (+1.64%)

HD Home Depot
$300.89 /

+4.85 (+1.64%)

HD Home Depot
$300.89 /

+4.85 (+1.64%)

HD Home Depot
$300.89 /

+4.85 (+1.64%)

Technical Analysis
Nasdaq 100 Index: Pivot points » 08:26
05/18/22
05/18
08:26
05/18/22
08:26
NDX

Nasdaq 100 Index

/

+

The following are the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NDX Nasdaq 100 Index
/

+

NDX Nasdaq 100 Index
/

+

NDX Nasdaq 100 Index
/

+

Recommendations
IAC price target lowered to $135 from $165 at Wells Fargo » 08:25
05/18/22
05/18
08:25
05/18/22
08:25
IAC

IAC

$82.16 /

+2.26 (+2.83%)

, ANGI

Angi Inc.

$4.96 /

+0.165 (+3.44%)

Wells Fargo analyst Brian…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IAC IAC
$82.16 /

+2.26 (+2.83%)

ANGI Angi Inc.
$4.96 /

+0.165 (+3.44%)

IAC IAC
$82.16 /

+2.26 (+2.83%)

05/11/22 Cowen
IAC price target lowered to $150 from $180 at Cowen
05/11/22 Wedbush
IAC price target lowered to $107 from $149 at Wedbush
05/11/22 Benchmark
IAC price target lowered to $175 from $200 at Benchmark
05/11/22 Oppenheimer
IAC price target lowered to $135 from $155 at Oppenheimer
ANGI Angi Inc.
$4.96 /

+0.165 (+3.44%)

05/11/22 Benchmark
IAC price target lowered to $175 from $200 at Benchmark
05/11/22 Oppenheimer
IAC price target lowered to $135 from $155 at Oppenheimer
05/11/22 Piper Sandler
Angi Inc. price target lowered to $5 from $8 at Piper Sandler
04/26/22 BMO Capital
Angi Inc. price target lowered to $8 from $12 at BMO Capital
IAC IAC
$82.16 /

+2.26 (+2.83%)

ANGI Angi Inc.
$4.96 /

+0.165 (+3.44%)

IAC IAC
$82.16 /

+2.26 (+2.83%)

ANGI Angi Inc.
$4.96 /

+0.165 (+3.44%)

IAC IAC
$82.16 /

+2.26 (+2.83%)

ANGI Angi Inc.
$4.96 /

+0.165 (+3.44%)

ANGI Angi Inc.
$4.96 /

+0.165 (+3.44%)

Earnings
Biosyent reports Q1 EPS C$0.13 vs. C$0.13 last year » 08:24
05/18/22
05/18
08:24
05/18/22
08:24
BIOYF

Biosyent

$6.49 /

+ (+0.00%)

Reports Q1 revenue C$7M…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BIOYF Biosyent
$6.49 /

+ (+0.00%)

BIOYF Biosyent
$6.49 /

+ (+0.00%)

03/10/22 Raymond James
Biosyent price target raised to C$8 from C$7.50 at Raymond James
Earnings
Target expects about $1B of incremental freight costs this year  08:24
05/18/22
05/18
08:24
05/18/22
08:24
TGT

Target

$215.30 /

-2.95 (-1.35%)

 
ShowHide Related Items >><<
TGT Target
$215.30 /

-2.95 (-1.35%)

TGT Target
$215.30 /

-2.95 (-1.35%)

05/16/22 Deutsche Bank
Target price target lowered to $294 from $353 at Deutsche Bank
05/16/22 Stifel
Target price target lowered to $270 from $280 at Stifel
04/08/22 Gordon Haskett
Gordon Haskett upgrades Target on 'remarkably consistent' traffic trends
04/08/22 Gordon Haskett
Target upgraded to Buy from Hold at Gordon Haskett
TGT Target
$215.30 /

-2.95 (-1.35%)

TGT Target
$215.30 /

-2.95 (-1.35%)

TGT Target
$215.30 /

-2.95 (-1.35%)

TGT Target
$215.30 /

-2.95 (-1.35%)

Upgrade
Salesforce upgraded to Buy from Neutral at Roth Capital » 08:24
05/18/22
05/18
08:24
05/18/22
08:24
CRM

Salesforce

$163.74 /

-0.47 (-0.29%)

Roth Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CRM Salesforce
$163.74 /

-0.47 (-0.29%)

CRM Salesforce
$163.74 /

-0.47 (-0.29%)

06:42 Today Mizuho
Salesforce price target lowered to $225 from $295 at Mizuho
05/17/22 UBS
Salesforce price target lowered to $185 from $225 at UBS
05/16/22 Morgan Stanley
Salesforce price target lowered to $291 from $360 at Morgan Stanley
05/12/22 OTR Global
Salesforce view downgraded to Mixed from Positive at OTR Global
CRM Salesforce
$163.74 /

-0.47 (-0.29%)

CRM Salesforce
$163.74 /

-0.47 (-0.29%)

CRM Salesforce
$163.74 /

-0.47 (-0.29%)

CRM Salesforce
$163.74 /

-0.47 (-0.29%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.